AlphaFold predicted structure
RIPK4 · P57078

Mean pLDDT
74.9/ 100
Confident
832 residues
Confidence breakdown
- Very high(≥ 90)47%
- Confident(70–90)24%
- Low(50–70)5%
- Very low(< 50)24%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
receptor interacting serine/threonine kinase 4
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Arthrogryposis
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalEctodermal dysplasia
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalStructural eye disease
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalBartsocas-Papas syndrome 1
CHAND syndrome
ectodermal dysplasia syndrome
atrial fibrillation
alcohol drinking
alopecia areata
self-injurious ideation
Alzheimer disease
multiple sclerosis
lysosomal storage disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Receptor-interacting serine/threonine-protein kinase 4
Serine/threonine protein kinase (By similarity). Required for embryonic skin development and correct skin homeostasis in adults, via phosphorylation of PKP1 and subsequent promotion of keratinocyte differentiation and cell adhesion (By similarity). It is a direct transcriptional target of TP63 (PubMed:22197488). Plays a role in NF-kappa-B activation (PubMed:12446564)
RIPK4 · P57078

Mean pLDDT
74.9/ 100
Confident
832 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0